OrphanDrug
OrphanDrug
Pharma Knowledge Base

chromosome 5q deletion syndrome

MeSH: C535323ORPHA: 86841

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with chromosome 5q deletion syndrome, sourced from HPO and Orphanet clinical annotations.

MyelodysplasiaAbnormal erythrocyte morphologyThrombocytosisMacrocytic anemiaErythroid hypoplasiaAbnormal megakaryocyte morphologyIncreased circulating lactate dehydrogenase concentrationBone marrow hypercellularityMegakaryocyte nucleus hypolobulationDecreased total leukocyte countAbnormal bleedingAcute myeloid leukemiaBone marrow hypocellularityAnisocytosisAbnormal neutrophil morphologyAbnormality of bone marrow stromal cellsMultiple lineage myelodysplasiaChronic infection

Classification & Codes

MeSH Code

C535323

Orphanet Code

ORPHA:86841
chromosome 5q deletion syndrome
MeSHC535323
OrphanetORPHA:86841
Treatments0 drug(s)
Symptoms on record18 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO